Cullinan Therapeutics, Inc. · NASDAQ:CGEM

Lynx1 Capital Management LP reported a 14.50% stake in Cullinan Therapeutics, Inc. (Schedule 13G/A)

Event Oct 8, 2025 · Filed Oct 10, 2025

Lynx1 Capital Management LP reported a 14.50% stake in Cullinan Therapeutics, Inc., 8,549,084 shares, as a passive investor on Oct 8, 2025. Filed Oct 10, 2025 (Schedule 13G/A).

Stake
14.50%
Shares
8,549,084
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Lynx1 Capital Management LP14.50%8,549,084
Weston Nichols14.50%8,549,084

Source

View original at SEC

Related